257 related articles for article (PubMed ID: 21191102)
1. Reversing chemoresistance by small molecule inhibition of the translation initiation complex eIF4F.
Cencic R; Hall DR; Robert F; Du Y; Min J; Li L; Qui M; Lewis I; Kurtkaya S; Dingledine R; Fu H; Kozakov D; Vajda S; Pelletier J
Proc Natl Acad Sci U S A; 2011 Jan; 108(3):1046-51. PubMed ID: 21191102
[TBL] [Abstract][Full Text] [Related]
2. Translation initiation complex eIF4F is a therapeutic target for dual mTOR kinase inhibitors in non-Hodgkin lymphoma.
Demosthenous C; Han JJ; Stenson MJ; Maurer MJ; Wellik LE; Link B; Hege K; Dogan A; Sotomayor E; Witzig T; Gupta M
Oncotarget; 2015 Apr; 6(11):9488-501. PubMed ID: 25839159
[TBL] [Abstract][Full Text] [Related]
3. Homogenous time resolved fluorescence assay to identify modulators of cap-dependent translation initiation.
Cencic R; Yan Y; Pelletier J
Comb Chem High Throughput Screen; 2007 Mar; 10(3):181-8. PubMed ID: 17346117
[TBL] [Abstract][Full Text] [Related]
4. RNA-tethering assay and eIF4G:eIF4A obligate dimer design uncovers multiple eIF4F functional complexes.
Robert F; Cencic R; Cai R; Schmeing TM; Pelletier J
Nucleic Acids Res; 2020 Sep; 48(15):8562-8575. PubMed ID: 32749456
[TBL] [Abstract][Full Text] [Related]
5. Components of the eIF4F complex are potential therapeutic targets for malignant peripheral nerve sheath tumors and vestibular schwannomas.
Oblinger JL; Burns SS; Akhmametyeva EM; Huang J; Pan L; Ren Y; Shen R; Miles-Markley B; Moberly AC; Kinghorn AD; Welling DB; Chang LS
Neuro Oncol; 2016 Sep; 18(9):1265-77. PubMed ID: 26951381
[TBL] [Abstract][Full Text] [Related]
6. Monitoring eIF4F Assembly by Measuring eIF4E-eIF4G Interaction in Live Cells.
Frosi Y; Ramlan SR; Brown CJ
J Vis Exp; 2020 May; (159):. PubMed ID: 32421011
[TBL] [Abstract][Full Text] [Related]
7. Vesicular stomatitis virus infection alters the eIF4F translation initiation complex and causes dephosphorylation of the eIF4E binding protein 4E-BP1.
Connor JH; Lyles DS
J Virol; 2002 Oct; 76(20):10177-87. PubMed ID: 12239292
[TBL] [Abstract][Full Text] [Related]
8. Chaperone hsp27 inhibits translation during heat shock by binding eIF4G and facilitating dissociation of cap-initiation complexes.
Cuesta R; Laroia G; Schneider RJ
Genes Dev; 2000 Jun; 14(12):1460-70. PubMed ID: 10859165
[TBL] [Abstract][Full Text] [Related]
9. Blocking eukaryotic initiation factor 4F complex formation does not inhibit the mTORC1-dependent activation of protein synthesis in cardiomyocytes.
Huang BP; Wang Y; Wang X; Wang Z; Proud CG
Am J Physiol Heart Circ Physiol; 2009 Feb; 296(2):H505-14. PubMed ID: 19074679
[TBL] [Abstract][Full Text] [Related]
10. Blocking eIF4E-eIF4G interaction as a strategy to impair coronavirus replication.
Cencic R; Desforges M; Hall DR; Kozakov D; Du Y; Min J; Dingledine R; Fu H; Vajda S; Talbot PJ; Pelletier J
J Virol; 2011 Jul; 85(13):6381-9. PubMed ID: 21507972
[TBL] [Abstract][Full Text] [Related]
11. Emerging therapeutics targeting mRNA translation.
Malina A; Mills JR; Pelletier J
Cold Spring Harb Perspect Biol; 2012 Apr; 4(4):a012377. PubMed ID: 22474009
[TBL] [Abstract][Full Text] [Related]
12. c-Myc and eIF4F are components of a feedforward loop that links transcription and translation.
Lin CJ; Cencic R; Mills JR; Robert F; Pelletier J
Cancer Res; 2008 Jul; 68(13):5326-34. PubMed ID: 18593934
[TBL] [Abstract][Full Text] [Related]
13. eIF4F: a retrospective.
Merrick WC
J Biol Chem; 2015 Oct; 290(40):24091-9. PubMed ID: 26324716
[TBL] [Abstract][Full Text] [Related]
14. Structural roles for human translation factor eIF3 in initiation of protein synthesis.
Siridechadilok B; Fraser CS; Hall RJ; Doudna JA; Nogales E
Science; 2005 Dec; 310(5753):1513-5. PubMed ID: 16322461
[TBL] [Abstract][Full Text] [Related]
15. Assembly of an active translation initiation factor complex by a viral protein.
Walsh D; Mohr I
Genes Dev; 2006 Feb; 20(4):461-72. PubMed ID: 16481474
[TBL] [Abstract][Full Text] [Related]
16. A novel inhibitor of cap-dependent translation initiation in yeast: p20 competes with eIF4G for binding to eIF4E.
Altmann M; Schmitz N; Berset C; Trachsel H
EMBO J; 1997 Mar; 16(5):1114-21. PubMed ID: 9118949
[TBL] [Abstract][Full Text] [Related]
17. Targeting the eIF4F translation initiation complex for cancer therapy.
Konicek BW; Dumstorf CA; Graff JR
Cell Cycle; 2008 Aug; 7(16):2466-71. PubMed ID: 18719377
[TBL] [Abstract][Full Text] [Related]
18. A novel interaction of Cap-binding protein complexes eukaryotic initiation factor (eIF) 4F and eIF(iso)4F with a region in the 3'-untranslated region of satellite tobacco necrosis virus.
Gazo BM; Murphy P; Gatchel JR; Browning KS
J Biol Chem; 2004 Apr; 279(14):13584-92. PubMed ID: 14729906
[TBL] [Abstract][Full Text] [Related]
19. Intrinsic RNA binding by the eukaryotic initiation factor 4F depends on a minimal RNA length but not on the m7G cap.
Kaye NM; Emmett KJ; Merrick WC; Jankowsky E
J Biol Chem; 2009 Jun; 284(26):17742-50. PubMed ID: 19414591
[TBL] [Abstract][Full Text] [Related]
20. Attacking a nexus of the oncogenic circuitry by reversing aberrant eIF4F-mediated translation.
Bitterman PB; Polunovsky VA
Mol Cancer Ther; 2012 May; 11(5):1051-61. PubMed ID: 22572598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
